Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study

American Heart Journal

Volumn 183, Issue , 2017, Pages 62-68

  Zettler, Marjorie E ^a   Peterson, Eric D ^b   McCoy, Lisa A ^b   Effron, Mark B ^a   Anstrom, Kevin J ^b   Henry, Timothy D ^c   Baker, Brian A ^d   Messenger, John C ^e   Cohen, David J ^f   Wang, Tracy Y ^b  

^a ELI LILLY AND COMPANY   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d DAIICHI SANKYO INC   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PRASUGREL; TICAGRELOR; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR BLOCKING AGENT; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; ARTICLE; BLEEDING; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG COST; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH INSURANCE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; AGED; ANALOGS AND DERIVATIVES; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; ECONOMICS; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT PREFERENCE; STATISTICS AND NUMERICAL DATA;

ADENOSINE; ADENOSINE DIPHOSPHATE; AGED; CARDIOVASCULAR DISEASES; DRUG SUBSTITUTION; FEMALE; HEMORRHAGE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PATIENT PREFERENCE; PLATELET AGGREGATION INHIBITORS; PRASUGREL HYDROCHLORIDE; PURINERGIC P1 RECEPTOR ANTAGONISTS; TICLOPIDINE;

EID: 84994507752     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2016.10.006     Document Type: Article

References (7)

1. 1. O'Gara, P.T., Kushner, F.G., Ascheim, D.D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127 (2013), e362–e425.
2. 2. Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130 (2014), e344–e426.
3. 3. Bagai, A., Peterson, E.D., Honeycutt, E., et al. In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the TRANSLATE-ACS study. Eur Heart J Acute Cardiovasc Care 4 (2015), 499–508.
4. 4. Bagai, A., Wang, Y., Wang, T.Y., et al. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. Circ Cardiovasc Interv 7 (2014), 585–593.
5. 5. Chin, C.T., Wang, T.Y., Anstrom, K.J., et al. Treatment with adenosine diphosphate receptor inhibitors—longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. Am Heart J 162 (2011), 844–851.
6. 6. Cutlip, D.E., Windecker, S., Mehran, R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007), 2344–2351.
7. 7. The GUSTO investigators, (eds.) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med, 329, 1993, 673–682.